FRESH-PEF8794-en
Longitudinal Study on Patients with Rheumatoid Arthritis and Study on Tolerance and Efficacy of Tocilizumab (REGistry-RoAcTEmra)
REGATE
| Name |
|---|
| France |
The main objective of the REGATE study is to identify the tolerance and efficacy of Tocilizumab currently used for Rheumatoid Arthritis (RA).
['Clinical data','Biological data']
Individuals
| Topic | Vocabulary | URI |
|---|---|---|
| Geriatrics | health theme | |
| Rheumatology | health theme | |
| cim-11 | http://id.who.int/icd/entity/2074372855 | |
| Healthcare system determinants: Use of care | health determinant | |
| Healthcare system determinants | health determinant |
{
"level_sex_clusion_I": [
"Male",
"Female"
],
"level_age_clusion_I": [
"Young Adult (19 to 24 years)",
"Adult (25 to 44 years)",
"Middle Aged (45 to 64 years)",
"Aged (65 to 79 years)",
"Aged, 80 and over (80 years and more)"
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| Jacques Morel |
| Jean Sibilia |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['Other']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2011 | 2012 |
Longitudinal or cohort study
Contact the principal investigator
Restricted access
| Name | |
|---|---|
| Jacques Morel | jacquesmorel@yahoo.com |
| Jean Sibilia | jean.sibilia@chru-strasbourg.fr |
FRESH-PEF8794-en